Thor Medical ASA – New share capital registered

Oslo, Norway, 23 January 2026 – Reference is made to the stock exchange announcement made by Thor Medical ASA on 6 January 2026 regarding issuance of new shares pursuant to the Company's incentive program. The share capital increase has now been registered in the Norwegian Register of Business Enterprises and the Company's new share capital is NOK 70,828,126.60 divided into 354,140,633 shares, each with a nominal value of NOK 0,20. Each share represents one vote in the Company's general meeting.

For further information please contact:

Brede Ellingsæter

Chief Financial Officer,

Tel: +47 472 38 440,

Email: brede.ellingseter@thormedical.com

 

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of alpha particle emitters produced from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Securities Trading Act.